Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,674.00
Bid: 1,686.00
Ask: 1,692.00
Change: -26.00 (-1.53%)
Spread: 6.00 (0.356%)
Open: 1,678.00
High: 1,722.00
Low: 1,674.00
Prev. Close: 1,700.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Sep 2009 16:37

RNS Number : 8819Y
Genus PLC
10 September 2009
 



10 September 2009

FOR IMMEDIATE RELEASE 

Genus plc

('Genus' or 'the Company')

Director/PDMR Shareholding

Of 119,386 ordinary shares of 10 pence each in the Company ('Ordinary Shares') that vested today in favour of Richard Wood, Chief Executive, under the Company's Performance Share Plan (the 'Plan'), 60,290 Ordinary Shares are being retained by Richard Wood as part of his shareholding in the Company. 49,096 Ordinary Shares were today sold on behalf of Richard Wood at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Richard Wood as a result of today's vesting and a further 10,000 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Richard Wood.

Richard Wood's direct shareholding in the Company now stands at 120,595 Ordinary Shares which represent 0.203% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 223,710 conditional shares and nil-cost options under the Plan.

Of 68,220 Ordinary Shares that vested today in favour of Ian Biggs, Chief Operating Officer for the Americas, under the Plan, 26,777 Ordinary Shares are being retained by Ian Biggs as part of his shareholding in the Company. 28,055 Ordinary Shares were today sold on behalf of Ian Biggs at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Ian Biggs as a result of today's vesting and a further 13,388 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Ian Biggs.

Ian Biggs' direct shareholding in the Company now stands at 30,152 Ordinary Shares which represent 0.051of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 85,932 conditional shares and nil-cost options under the Plan.

Of 42,700 Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer for Europe and The Far East, under the Plan, 16,760 Ordinary Shares are being retained by Thomas Philip Acton as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Thomas Philip Acton as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Thomas Philip Acton.

Thomas Philip Acton's direct shareholding in the Company now stands at 37,864 Ordinary Shares which represent 0.064% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 78,627 conditional shares and nil-cost options under the Plan.

Of 42,700 Ordinary Shares that vested today in favour of Steve Amies, Chief Operating Officer for Global Research & Product Development, under the Plan, 16,760 Ordinary Shares are being retained by Steve Amies as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Steve Amies at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Steve Amies as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Steve Amies.

Steve Amies' direct shareholding in the Company now stands at 16,760 Ordinary Shares which represent 0.028% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 58,623 conditional shares and nil-cost options under the Plan.

 

For further information please contact:

 

Ian Farrelly Tel: 01256 345996

Group Company Secretary & General Counsel

Genus plc

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUROVRKBRKAAR
Date   Source Headline
1st Aug 20142:00 pmRNSBlock Listing 6 Monthly Return
8th Jul 20143:34 pmRNSHolding(s) in Company
7th Jul 20148:42 amRNSHolding(s) in Company
4th Jul 20141:43 pmRNSHolding(s) in Company
2nd Jul 20145:03 pmRNSHolding(s) in Company
1st Jul 201410:00 amRNSTotal Voting Rights
9th Jun 20142:00 pmRNSCompany Secretary Change
27th May 20147:00 amRNSUpdate on Shennong Joint Venture in China
15th May 20147:00 amRNSInterim Management Statement
15th May 20147:00 amRNSStrategic Beef Partnership with ABP Food Group
3rd Apr 20144:29 pmRNSDirector/PDMR Shareholding
28th Mar 20142:22 pmRNSDirector/PDMR Shareholding
19th Mar 20144:05 pmRNSBoard Appointments
17th Mar 20144:35 pmRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSInterim Results
10th Feb 20147:00 amRNSCompletion of Acquisition of Genetiporc do Brasil
31st Jan 20142:00 pmRNSBlocklisting Interim Review
31st Jan 20142:00 pmRNSTotal Voting Rights
31st Dec 201312:41 pmRNSTotal Voting Rights
31st Dec 201312:41 pmRNSDirector/PDMR Shareholding
12th Dec 20133:00 pmRNSDirector/PDMR Shareholding
29th Nov 20135:01 pmRNSTotal Voting Rights
15th Nov 20133:02 pmRNSResult of AGM
15th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20134:25 pmRNSTotal Voting Rights
29th Oct 20132:30 pmRNSHolding(s) in Company
18th Oct 20137:00 amRNSCompletion of Acquisition of Génétiporc
10th Oct 20134:35 pmRNSAnnual Report & Annual General Meeting
3rd Oct 20132:00 pmRNSAdditional Listing
2nd Oct 20135:00 pmRNSTotal Voting Rights
27th Sep 20136:19 pmRNSDirector/PDMR Shareholding
23rd Sep 20137:00 amRNSGenus to Acquire Génétiporc
3rd Sep 20133:04 pmRNSCorrection of Record Date
3rd Sep 20137:00 amRNSPreliminary Results
31st Jul 20133:00 pmRNSBlocklisting Interim Review
25th Jul 201310:14 amRNSCompany Secretary Appointment
18th Jul 20139:00 amRNSHolding(s) in Company
11th Jun 20135:07 pmRNSHolding(s) in Company
4th Jun 20139:10 amRNSHolding(s) in Company
31st May 20132:00 pmRNSTotal Voting Rights
23rd May 20138:22 amRNSDirector/PDMR Shareholding
21st May 20134:56 pmRNSHolding(s) in Company
30th Apr 20137:00 amRNSInterim Management Statement
8th Apr 20136:09 pmRNSHolding(s) in Company
8th Apr 201310:27 amRNSHolding(s) in Company
28th Mar 20134:13 pmRNSHolding(s) in Company
28th Mar 20133:51 pmRNSTotal Voting Rights
21st Mar 20132:00 pmRNSHolding(s) in Company
11th Mar 20134:07 pmRNSDirector/PDMR Shareholding
4th Mar 20132:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.